Jan. 7, 2020:

Investigator Spotlight:

Benjamin Teply, MD, University of Nebraska Medical Center

Research interests:

I am a medical oncologist engaged in clinical and translational research in genitourinary malignancies, with a special focus in prostate cancer. I have worked on novel treatment strategies for prostate cancer, with a focus on mechanisms other than suppression of androgen signaling, in both treatment-naïve (such as PARP inhibition) and castration-resistant prostate cancer (such as therapeutic high-dose testosterone). I am also dedicated in optimizing the use of approved therapies to maximize patient benefit.

Educational background

  • AB, Harvard College; MS, University of Michigan; MD, University of Nebraska College of Medicine; Residency in Internal Medicine, University of Michigan; Fellowship in Medical Oncology, Johns Hopkins University

Little-known facts about Dr. Teply

  • I joined the Big Ten (2003) earlier than Nebraska joined (2011), as an alumnus from the University of Michigan having studied biomaterials in the College of Engineering.
  • I spend most of my time outside of work with my 3 sons, ages 4 years, 2 years, and 4 months.
  • I have a collection of souvenir cups from the College World Series, which I have been attending in Omaha since 1986.


About the Big Ten Cancer Research Consortium: The Big Ten Cancer Research Consortium was created in 2013 to transform the conduct of cancer research through collaborative, hypothesis-driven, highly translational oncology trials that leverage the scientific and clinical expertise of Big Ten universities. The goal of the Big Ten Cancer Research Consortium is to create a unique team-research culture to drive science rapidly from ideas to new approaches to cancer treatment. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow with the unified goal of improving the lives of all patients with cancer.

About the Big Ten Conference: The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in the lives of students competing in intercollegiate athletics and emphasize the values of integrity, fairness and competitiveness. The broad-based programs of the 14 Big Ten institutions will provide over $200 million in direct financial support to almost 9,500 students for more than 11,000 participation opportunities on 350 teams in 42 different sports. The Big Ten sponsors 28 official conference sports, 14 for men and 14 for women, including the addition of men’s ice hockey and men’s and women’s lacrosse since 2013. For more information, visit www.bigten.org.